Loomis, Sayles & Company’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-335,738
Closed -$21.5M 1064
2023
Q1
$21.5M Buy
335,738
+2,789
+0.8% +$182K 0.04% 226
2022
Q4
$16.2M Sell
332,949
-7,962
-2% -$499K 0.03% 254
2022
Q3
$24.1M Sell
340,911
-4,117
-1% -$352K 0.05% 190
2022
Q2
$24.5M Sell
345,028
-1,751
-0.5% -$113K 0.05% 210
2022
Q1
$27.7M Sell
346,779
-6,613
-2% -$492K 0.04% 242
2021
Q4
$32.3M Sell
353,392
-9,308
-3% -$999K 0.04% 242
2021
Q3
$46.6M Sell
362,700
-5,463
-1% -$764K 0.06% 159
2021
Q2
$56.1M Sell
368,163
-157,995
-30% -$20.8M 0.07% 127
2021
Q1
$55.5M Sell
526,158
-99,649
-16% -$9.98M 0.07% 120
2020
Q4
$49.6M Sell
625,807
-3,647
-0.6% -$267K 0.07% 132
2020
Q3
$35.6M Buy
629,454
+11,931
+2% +$643K 0.05% 145
2020
Q2
$38M Buy
617,523
+86,233
+16% +$3.52M 0.06% 123
2020
Q1
$17.1M Buy
531,290
+86,089
+19% +$2.9M 0.04% 195
2019
Q4
$15.7M Buy
+445,201
New +$14.7M 0.03% 267

Other funds holding STAA

Loomis, Sayles & Company's STAA Position: Q2 2023 in Review

Loomis, Sayles & Company sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 335,738 shares — an estimated $21.5M sold.

Loomis, Sayles & Company first reported a position in STAA in Q4 2019 and held it in 14 quarters. The position peaked at $56.1M in Q2 2021. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Loomis, Sayles & Company reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 335,738 STAAR Surgical shares in Q2 2023, an estimated $21.5M.
  • Loomis, Sayles & Company first reported a position in STAAR Surgical in Q4 2019 and held it in 14 quarters.
  • Loomis, Sayles & Company's STAAR Surgical position peaked at $56.1M in Q2 2021.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.